Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Investor Relations
  3. Press releases, Ad-hocs & Related Party Transactions
Investor relations

Press releases, Ad-hocs & Related Party Transactions

3min

Latest press releases

Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available
Tarrytown, New York, USA
Siemens Healthineers is expanding its brain health research offerings with the launch of automated pTau217 and BDTau immunoassays for research use. Blood-based biomarker testing offers a less-invasive method compared to cerebrospinal fluid which requires a lumbar puncture.

Siemens Healthineers Presents New Angiography Systems with AI to Aid Precise Embolization Treatment of Liver Cancer
Vienna, Austria
At this year’s ECR, Siemens Healthineers is highlighting the new angiography platforms Artis genio, Artis icono.explore and Artis icono.vision. Features include automated motion correction in three-dimensional cone beam computed tomography datasets, software for accurate planning and device navigation, and the new Optiq AI imaging chain for higher image quality at the same dose.

Ad-hoc announcements & Related Party Transactions

Here you will find all ad hoc announcements (disclosure of inside information according to Article 17 of Regulation (EU) No 596/2014 on market abuse) and announcements of material transactions with related parties in accordance with section 111c of the German Stock Corporation Act of Siemens Healthineers AG.